Security Asset Management’s West Pharmaceutical WST Stock Holding History

Security Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$4.04M	Sell	11,669 -2,824	-19%	-$825K	2.37%	12
2022 Q4	$3.41M	Hold	14,493	–	–	1.89%	23
2022 Q3	$3.57M	Sell	14,493 -8	-0.1%	-$2.44K	2.14%	17
2022 Q2	$4.38M	Sell	14,501 -295	-2%	-$96K	2.41%	15
2022 Q1	$6.08M	Sell	14,796 -85	-0.6%	-$33.3K	2.61%	11
2021 Q4	$6.98M	Sell	14,881 -345	-2%	-$149K	2.71%	10
2021 Q3	$6.46M	Sell	15,226 -1,385	-8%	-$584K	2.61%	10
2021 Q2	$5.96M	Sell	16,611 -671	-4%	-$222K	2.35%	12
2021 Q1	$4.87M	Sell	17,282 -2,408	-12%	-$689K	2%	14
2020 Q4	$5.58M	Buy	19,690 +3,891	+25%	+$1.09M	2.33%	10
2020 Q3	$4.34M	Sell	15,799 -1,180	-7%	-$312K	2.67%	8
2020 Q2	$3.86M	Sell	16,979 -4,300	-20%	-$845K	2.38%	10
2020 Q1	$3.24M	Hold	21,279	–	–	2.3%	14
2019 Q4	$3.2M	Hold	21,279	–	–	1.91%	21
2019 Q3	$3.02M	Hold	21,279	–	–	1.99%	21
2019 Q2	$2.66M	Hold	21,279	–	–	1.71%	24
2019 Q1	$2.35M	Buy	21,279 +25	+0.1%	+$2.6K	1.55%	26
2018 Q4	$2.08M	Hold	21,254	–	–	1.59%	25
2018 Q3	$2.62M	Buy	21,254 +75	+0.4%	+$8.41K	1.72%	22
2018 Q2	$2.1M	Buy	21,179 +2,100	+11%	+$193K	1.48%	28
2018 Q1	$1.68M	Buy	19,079 +8,729	+84%	+$817K	1.26%	33
2017 Q4	$1.02M	Buy	+10,350	New	+$1.01M	0.77%	44

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Security Asset Management's WST Position: Q1 2023 in Review

Security Asset Management reduced its West Pharmaceutical (WST) stake by 19% in Q1 2023, selling an estimated $825K and leaving 11,669 shares worth $4.04M. The position accounts for 2.37% of the portfolio, ranked #12.

Security Asset Management first reported a position in WST in Q4 2017 and has held it in 22 quarters since. The position peaked at $6.98M in Q4 2021. 696 funds tracked by Wall St. Rank hold WST as of Q1 2023.

Security Asset Management held 11,669 shares of West Pharmaceutical worth $4.04M as of Q1 2023.
Security Asset Management sold 2,824 West Pharmaceutical shares in Q1 2023, an estimated $825K.
West Pharmaceutical made up 2.37% of Security Asset Management's portfolio in Q1 2023, its #12 holding.
Security Asset Management first reported a position in West Pharmaceutical in Q4 2017 and has held it in 22 quarters since.
Security Asset Management's West Pharmaceutical position peaked at $6.98M in Q4 2021.
696 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Security Asset Management's 13F filing for Q1 2023, filed 12 May 2023.